Introduction ▼
Melatonin, the hormone of the night, has a wide range of physiological actions in such diverse tissues as the suprachiasmatic and other brain nuclei, pancreatic B cells, brown adipose tissue, diverse vascular territories, immune system, and also on steroid secreting glands [1 -3] . Within the latter, we demonstrated that melatonin, acting directly on the adrenal gland, inhibits glucocorticoid response to ACTH in nonhuman primates, sheep, and rats [4 -6] . Suggestive that this may also extend to humans, we found that the human adrenal gland expresses the MT 1 receptor and that melatonin acutely depresses cortisol response to ACTH in dexamethasone suppressed men [7] . We and others have demonstrated that in the nonhuman primate and rodent adrenal gland, 
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Abstract ▼
In nonhuman primates and rodents, melatonin acting directly on the adrenal gland, inhibits glucocorticoid response to ACTH. In these species, an intrinsic adrenal circadian clock is involved in ACTH-stimulated glucocorticoid production. We investigated whether these fi ndings apply to the human adrenal gland by determining i) expression of clock genes in vivo and ii) direct eff ects of melatonin in ACTH-stimulated adrenal explants over a) expression of the clock genes PER1 (Period 1) mRNA and BMAL1 [Brain-Muscle (ARNT)-like] protein, ACTH-induced steroidogenic acute regulatory protein (StAR), and 3 β -hydroxysteroid dehydrogenase (3 β -HSD) and b) over cortisol and progesterone production. Adrenal tissue was obtained from 6 renal cancer patients undergoing unilateral nephrectomy-adrenalectomy. Expression of the clock genes PER1 , PER2 , CRY2 (Cryptochrome 2), CLOCK (Circadian Locomotor Output Cycles Kaput) and BMAL1 , was investigated by RT-PCR in a normal adrenal and in an adenoma. In independent experiments, explants from 4 normal adrenals were preincubated in culture medium (6 h) followed by 12 h in: medium alone; ACTH (100 nM); ACTH plus melatonin (100 nM); and melatonin alone. The explants ' content of PER1 mRNA (real-time PCR) and StAR, 3 β -HSD, BMAL1 (immuno slot-blot), and their cortisol and progesterone production (RIA) were measured. The human adrenal gland expresses the clock genes PER1 , PER2 , CRY2 , CLOCK , and BMAL1 . ACTH increased PER1 mRNA, BMAL1, StAR, and 3 β -HSD protein levels, and cortisol and progesterone production. Melatonin inhibited these ACTH eff ects. Our study demonstrates, for the fi rst time, direct inhibitory eff ects of melatonin upon several ACTH responses in the human adrenal gland.
In the human adrenal gland, information about direct interactions of melatonin, clock genes and ACTH is not available. A limitation in studying such interactions is that only few clinical conditions require removal of a healthy human adrenal gland. In the present study, we used normal adrenal tissue from a small number of renal cancer patients undergoing laparoscopic unilateral nephrectomy-adrenalectomy for removal of an upper pole renal carcinoma. In these human adrenals, we explored the interactions of melatonin and clock genes under ACTH stimulation and its overall eff ect on cortisol production. We investigated: i) expression of clock genes in the human gland ex vivo and ii) direct eff ects of melatonin on ACTH-stimulated human adrenal gland explants over a) expression of the clock genes PER1 mRNA and BMAL1 protein, ACTH-induced steroidogenic acute regulatory protein (StAR), and 3 β -hydroxysteroid dehydrogenase (3 β -HSD) and b) over cortisol and progesterone production.
Subjects and Methods

▼ Subjects
Adrenal tissue was obtained from patients undergoing laparoscopic unilateral nephrectomy-adrenalectomy for removal of an upper pole renal carcinoma. Patients were recruited at the Hospital Cl í nico de la Pontifi cia Universidad Cat ó lica de Chile from cases not treated with medication that alters adrenal function. Adrenals from 6 renal cancer patients (48 to 77 years old) that met the criteria described below were collected at diff erent dates over 2 years. 5 adrenal glands were removed between 10:00 -12:00 h and one at 17:00 h. The experimental protocols were explained to the subjects and they provided written informed consent, according to the guidelines of the Declaration of Helsinki. The protocol was approved by the Ethical Committee of the Facultad de Medicina, Pontifi cia Universidad Cat ó lica de Chile.
Methods
Adrenal tissue preparation and experimental protocol
At each surgical intervention, samples of adrenal tissue (about 100 -400 mg, judged to be mainly cortex by the surgeon ' s criteria) were sent to our laboratory and to pathology. As we could not know in advance whether the adrenals were normal, when the amount of tissue was adequate, adrenals were cut into explants as soon as received from the surgery room, and cultured following the experimental procedures described below. If tissue was scant, adrenals were collected only in TRIzol. Experiments were analyzed when the pathology report was normal. Adrenal samples from 2 patients were stored in TRIzol and processed later to identify expression of the clock genes PER1 , PER2 , CRY2 , CLOCK , and BMAL1 by RT-PCR. These adrenals were determined to be a normal gland and an adenoma. Adrenal specimens from the other 4 patients were reported by pathology as normal. Fresh human adrenal gland explants were prepared, as previously described [4] , immediately after receiving the surgical specimens. In brief, adrenal glands were cut in small explants (about 15 -30 mg) which were mixed, suspended, and preincubated at 37 ° C, 5 % CO 2 for 6 h starting at 14:00 h. The adrenal tissue obtained at 17:00 h was maintained overnight at 4 ° C, and treatment was initiated at 14:00 h the next day. At 20:00 h, explants were incubated in triplicate for 12 h in 2 ml medium alone (control) or containing 100 nM of 1 -24 ACTH, 100 nM ACTH + 100 nM melatonin or 100 nM melatonin alone. Incubations ended at 08:00 h. After incubation, the medium was collected and stored at − 20 ° C to measure cortisol and progesterone production. The explants were weighed and processed in TRIzol for mRNA and protein extraction. Our experiments explored the interaction between ACTH and melatonin at an approximate night time clock time interval (20:00 h to 08:00 h), hours at which the human adrenal is normally exposed to the nocturnal increase of melatonin [1] . The dose of ACTH was selected after corroborating in 2 independent experiments, that 100 nM elicits a maximal cortisol response in the human adrenal gland. The 100 nM dose of melatonin was chosen based on our previous studies using adrenal gland explants from other mammals [1 -6, 14] in which 10 -100 nM of melatonin inhibited ACTH-stimulated cortisol production. 
RT-PCR
Total RNA was extracted with TRIzol according to the manufacturer ' s instructions from one normal human adrenal, an adrenal adenoma, and from human adrenal explants after incubation. Total RNA concentrations were measured by absorbance at 260 nm. cDNAs were synthesized from 3 μ g of total RNA using random hexamers. For semi-quantitative PCR reactions, samples were analyzed at 150 -300 ng equivalents to total RNA per tube. Primers were: PER2 (for:
. All primers utilized pass through an intron, avoiding DNA amplifi cation. PCR conditions for PER2 , CLOCK , and BMAL1 were: 4 min at 94 ° C initial denaturation followed by 36 cycles of 1 min at 94 ° C, 1 min at 54 ° C, 2 min 72 ° C, and 10 min of fi nal extension at 72 ° C. Conditions for PER1 and CRY2 were similar, except for using 60 ° C and 61 ° C, respectively, as annealing temperature. A control without template and a control without reverse transcription were included in each PCR run. PCR products were separated by electrophoresis on a 2 % agaroseethidium bromide gel. The gel image was captured with a digital camera (Olympus CamediaMaster 4.1, Tokio, Japan) using DocIT Software (UVO, Inc., Upland, CA). The expected PCR products size for PER1 , PER2 , CRY2 , CLOCK , and BMAL1 were 404 bp, 282 bp, 525 bp, 386 bp, and 564 bp, respectively. In adrenal explants, RNA was extracted as described above and then treated with DNAse using SV Total RNA Isolation System according to the manufacturer ' s instructions. PER1 and 18S rRNA gene expression was measured by real-time PCR system (StepOne, Applied Bioystem) using the primers for PER1 described above and for 18S -rRNA (for: 5 ′ -gtaacccgttgaaccccatt-3 ′ , rev: 5 ′ -ccatccaatcggtagtagcg-3 ′ [17] ). The fi nal reaction volume was 12.5 μ l (6.25 μ l SYBR Green Master Mix, 0.375 μ l sense and antisense primers 0.3 μ M, 3.0 μ l free nuclease water, and 2.5 μ l cDNA). The melting temperature (melting point or Tm) of the PCR product for PER1 was 84 ° C and for 18S -rRNA was 78 ° C. Product size was confi rmed by gel electrophoresis. The Per1 PCR product was purifi ed using Wizard SV gel and PCR clean-up System (Promega), following the manufacturer ' s instructions. Sequencing was performed in a Genetic Analyzer ABI PRISM 310, Applied Biosystems, at the Unidad de Diversidad Molecular, Departamento de Ecolog í a, Pontifi cia Universidad Cat ó lica de Chile. 92 % of the PCR product was completely sequenced showing 100 % identity with bases 582 -929 of the reported sequence of human PER1 (GenBank accession number NM_002616.21). Samples were measured using a standard curve constructed with serial dilutions of known quantities for PER1 and 18S -rRNA products. These products were prepared by conventional PCR, purifi ed, amplifi ed, and quantifi ed by densitometry against a 300 bp DNA marker of known concentration, and fi nally stored in aliquots at − 20 ° C. Nontemplate controls were included in every PCR reaction and a cDNA pool was included to assess inter assay variability. The threshold cycle (Ct) of each sample and the internal control was interpolated in the respective standard curve. PER1 and 18S -rRNA concentration in each sample was measured in several cDNA dilutions (equivalent to 30 to 0.3 ng RNA for PER1 and to 4 to 0.02 ng for 18S -rRNA). The ratio PER1 / 18S -rRNA was calculated for each sample and normalized by calculating the percentage of each treatment with respect to control. Inter assay variation was 6 % for 18S-rRNA and 10 % for PER1 .
Semi-quantifi cation of BMAL1, StAR, and 3 β -HSD protein levels in human adrenal gland explants
The protein levels of BMAL1, StAR, and 3 β -HSD in adrenal explants from the adrenal glands of 3 patients were measured by an amplifi ed slot-blot technique using specifi c antibodies, which recognize single bands by Western blot of 68 kDa, 30 kDa, and 43 kDa, respectively [8] . The yield of protein from the adrenal gland explants of the fourth patient was insuffi cient to perform the measurements. Total adrenal proteins were extracted from adrenal explants by TRIzol following the manufacturer ' s instructions. The protein concentration was measured by spectrophotometry at 280 nm using 16.66 μ M albumin, as standard. 10 micrograms of protein in 50 μ l of SDS 1 % w / v were applied to wet PVDF membranes (0.45 μ m) followed by the procedure previously described [8] . Each blot image was scanned using a digital Scanner (AGFA SNAPSCAN 310, Mortsel Belgium), then optical density (pixels / mm 2 ) of a square of fi xed size comprising the spot, was measured with the software Scion Image (ScionCorporation, http://www.scioncorp.com ). Membranes stained with Coomasie blue were used as additional loading controls. Each sample was measured in 3 independent assays. BMAL1, StAR, and 3 β -HSD protein levels were expressed per μ g of protein and normalized by calculating the percentage of each treatment with respect to control treatment.
Cortisol and progesterone production by human adrenal gland explants
Concentrations of cortisol and progesterone in culture medium from incubated adrenal glands from 4 patients were measured by RIA, as described previously [18] . Inter-and intra-assay coeffi cients were less than 15 % . Cortisol and progesterone production were expressed per mg of tissue. Control cortisol production per mg of adrenal tissue ranged from 21.2 to 157.8 pmol (7.7 -57.2 ng). Control progesterone production ranged from 0.20 to 1.31 pmol (63 -413 pg). For both steroids, the data were normalized by calculating the percentage of each treatment with respect to control in each experimental protocol.
Data analysis
Data were expressed as mean ± S.E.M. Diff erences between means were analyzed by repeated measures ANOVA and Newman-Keuls as post hoc test. Data expressed as percentage was transformed to arcsine before analysis. Statistical analysis was performed using GraphPad Prism 4 Software. Diff erences were considered signifi cant at p < 0.05.
Results
▼ Expression of clock genes by the human adrenal gland ex vivo
We detected expression of PER1 , PER2 , CRY2 , CLOCK , and BMAL1 genes in the samples assayed immediately after surgery, refl ecting the in vivo situation as close as possible . As shown in • ▶ Fig. 1 , PCR products of the expected size for these genes were present in a normal adrenal gland as well as in the adrenal adenoma. Using cDNA equivalent to 150 ng of RNA, weak bands for CRY2 , PER2 , CLOCK , and BMAL1 were obtained. In contrast, a heavily saturated band was obtained for PER1 suggesting a higher abundance than that of the other genes. Given this observation, and the limitations in the amount of RNA obtained in adrenal explants after DNAse treatment, we decided to quantify just PER1 expression in adrenal explants by real-time PCR.
Melatonin inhibits PER1 mRNA and BMAL1 protein expression induced by ACTH in human adrenal gland explants
Quantifi cation of PER1 content in human adrenal explants revealed that ACTH (100 nM) treatment increased expression of PER1 mRNA. At 12 h of incubation, PER1 expression was about 3 times higher than in control explants and explants treated only with melatonin ( • ▶ Fig. 2a ). The increase of PER1 mRNA induced by ACTH was suppressed by addition of 100 nM melatonin to the culture medium. Treatment with melatonin alone decreased Per1 mRNA expression to values lower than in control explants in 3 of the 4 adrenal glands studied, but the diff erence between means was not statistically signifi cant. ACTH treatment increased the expression of BMAL1 protein at 12 h of incubation in the adrenal explants from the 3 patients studied ( • ▶ Fig. 2b ). This increase was abrogated by addition of 100 nM melatonin to the culture medium. Expression of BMAL1 protein in explants treated with melatonin alone was not diff erent from that in control or ACTH treated explants.
Melatonin inhibits cortisol and progesterone production induced by ACTH and suppresses StAR and 3 β -HSD protein levels in human adrenal gland explants ACTH (100 nM) treatment stimulated cortisol and progesterone production in human adrenal explants ( • ▶ Fig. 3a, b ) . ACTH treated explants produced nearly 3 times the amount of cortisol and about 2 times the amount of progesterone than control explants treated with medium alone (range 2.2-to 3.1-fold and 1.3-to 3.2-fold, respectively) and contained about twice the amount of StAR and 3 β -HSD protein than control explants ( • ▶ Fig. 3c, d ). Incubation with 100 nM melatonin blocked the ACTH stimulation of cortisol and progesterone production and of StAR and 3 β -HSD protein levels near to control values. Treatment with 100 nM melatonin alone had no eff ect on cortisol or progesterone production and on protein expression of StAR and 3 β -HSD respect to control treatment ( • ▶ Fig. 3a -d ).
Discussion ▼
Our study provides evidence of expression of circadian clock genes in the human adrenal and report a novel stimulatory eff ect of ACTH upon PER1 mRNA and BMAL1 protein expression. Melatonin inhibited the former responses as well as the known stimulation by ACTH of StAR and 3 β -HSD protein levels and of cortisol and progesterone production. Thus, notwithstanding the limitations imposed by the number of cases and amount of tissue available, our study demonstrates, for the fi rst time, direct inhibitory eff ects of melatonin in several aspects of the human adrenal gland response to ACTH. The expression of PER1 , PER2 , CRY2 , CLOCK , and BMAL1 mRNA in the human adrenal cortex samples, measured immediately after surgery, suggests that in vivo the human adrenal gland contains a circadian clock. Clock gene expression represents the contribution of diverse cell types present in the adrenal cortex: steroidogenic cells, endothelial cells, fi broblasts and possibly of a few chromaffi n cells. Clock gene expression has been reported in the nonhuman primate adrenal gland and rodent adrenal gland [13, 19, 20] . In the former species, adrenal gland explants sustain oscillatory expression of clock genes in culture, situation not tested in the present experiments. However, measured at a single time point, 12 h of incubation, clock gene expression persisted in cultured human adrenal explants. Furthermore, at this time interval, we found that PER1 mRNA levels were higher in ACTH treated explants than in control explants incubated with medium alone. Additionally, with the increase in PER1 mRNA levels, the human adrenal explants incubated with ACTH for 12 h, contained higher levels of BMAL1 protein than the control explants. Given the reciprocal interaction between BMAL1 and PER1 , the increase in BMAL1 protein in response to ACTH may be responsible for the PER1 mRNA increase [21, 22] . On the other hand, it is known that increases in PER1-2 , most likely accompa- nied by increases in CRY1-2 expression, could result in PER / CRY protein mediated upregulation of BMAL1 transcription [23] . The ACTH induction of PER1 mRNA expression and of BMAL1 protein levels in the human adrenal gland explants was inhibited by simultaneous treatment with melatonin. In addition, melatonin inhibited the 4 other responses to ACTH studied: increases in StAR and 3 β -HSD protein expression and in cortisol and progesterone production. Similar direct inhibitory eff ects of melatonin over ACTH-stimulated cortisol production have been shown in the NCIH295R human adrenocortical carcinoma cell line [24] and in the adrenals of several species over ACTH-stimulated glucocorticoid and progesterone production and 3 β -HSD mRNA expression [4 -6, 8, 14] . In the conditions of the present experiments, ACTH induction of BMAL1 protein coincided with an increased expression of StAR. This protein is inducible by BMAL1 [11] whereas its expression is decreased in corpora lutea, testis, and adrenal gland of BMAL1 ( -/ -) female and male mice that show low progesterone and testosterone levels, respectively [25, 26] . Clock genes may participate in the regulation of other steroidogenic enzymes as CRY null mice that have excessive aldosterone production and hypertension, overexpress 3 β -HSD6 in the adrenal zona glomerulosa [27] . 2 lines of evidence, using knockout rats and direct clock gene knock-in, showed that adrenal glucocorticoid response to ACTH in rats and nonhuman primates requires an intact adrenal clockwork [8 -10] . On the other hand, melatonin has been shown to directly inhibit clock gene expression in the capuchin monkey adrenal [13] and in striatal neurons of mice [28] . In the present experiments, we cannot identify the precise human adrenal cell type upon which melatonin acted. In adrenal explants, the anatomic architecture remains, thus steroidogenic cells are in close contact with endothelial cells and fi broblasts, and possibly, a few chromaffi n cells dispersed in the cortex, are potential providers of paracrine signals that modulate steroid response to ACTH [29] . Albeit the former, the similitude of the pattern of change of cortisol and progesterone production and of StAR and 3 β -HSD protein content of human adrenal gland explants in response to ACTH and ACTH plus melatonin, was strikingly similar to that of PER1 mRNA and BMAL1 protein content, suggesting that melatonin acted on the link between ACTH, clock genes, and adrenal steroidogenesis. In vivo, adrenal cortex regulation of cortisol production is complex, involving the coordinated action of ACTH, adrenal innervation, and local adrenal factors [29 -31] , and possibly melatonin [4] . In the human adrenal gland, the present experiments, notwithstanding their limitations, suggest the involvement of adrenal clock gene expression in the mechanisms by which ACTH stimulates cortisol production and by which melatonin directly inhibited this production. Elucidating further the interaction between ACTH, clock genes, and melatonin in the human adrenal gland can provide new insights into the regulation of cortisol production, a key hormone for physiological homeostasis. 
